PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15694923-1	2005	Galantamine is a rather weak acetylcholinesterase (AChE) inhibitor, currently approved for the symptomatic treatment of Alzheimer"s disease, with possible additional allosteric potentiating effects at the nicotinic ACh receptor (nAChR).	Galantamine	0-11	cholinergic receptor nicotinic epsilon subunit	Rattus norvegicus	205-227	
15694923-1	2005	Galantamine is a rather weak acetylcholinesterase (AChE) inhibitor, currently approved for the symptomatic treatment of Alzheimer"s disease, with possible additional allosteric potentiating effects at the nicotinic ACh receptor (nAChR).	Galantamine	0-11	cholinergic receptor nicotinic epsilon subunit	Rattus norvegicus	229-234